The genomics and proteomics sector is comprised of approximately 64 small but growing companies, whose work is roughly distributed in four categories: genomics-based development companies, toolmakers, bioinformatics software providers and information companies. Research has been the focal point of genomics efforts within the Government of Canada. In the last five years, strategic funding through Genome Canada has catapulted Canada into one of the best places in the world to do genomics and proteomics research.

Please visit Genome Canada for more information on Canada's Genomics and Proteomics industries.

Canada's Support of the Genomics & Proteomics Sectors: The Government of Canada has a number of intramural and extramural genomic initiatives that include proteomics. For example, $55 million over three years was allocated in 1999 and an additional $59.7 million over three years was allocated in each of 2002 and 2005 for genomics research at federal laboratories. Since 2000, $600 million has been directed to Genome Canada, which has raised to date over $400 million in matching funding. Between 2000 and 2005, Genome Canada funded 80 projects, and in August 2005, the results for Competition III were announced, with $346 million to be invested in 33 innovative, large-scale projects for a duration of three to four years. In addition, the government indirectly supports research in genomics/proteomics by funding projects through CIHR and the Network of Centres of Excellence (NCE) Program. There are two NCEs which have proteomics components: The Stem Cell Network, established in 2000, which performs research in the area of genomics; and, Protein Engineering Network of Centres of Excellence (PENCE), which has a significant research thrust in proteomics.